Gary Schiller, MD
Chief, Therapeutic Hemapheresis
Professor, Hematology/Oncology, Pathology and Laboratory Medicine
Physician, UCLA Oncology Center, Transfusion Medicine
UCLA Medical Center
| Contact Information (Information/referral/appointments) | ||
| Hematology/Oncology: | (310) 206-6909 | |
| Therapeutic Hemapheresis: | (310) 794-7177 | |
| Transfusion Medicine: | (310) 825-4968 | |
| UCLA Oncology Center: | (310) 206-6931 | |
Biography
| Practice Information: |
Clinical Interest: Antiphospholipid Bone Marrow Transplant Chronic Myelogenous Leukemia General Hematology Hematologic Malignancies Leukemia Lymphoma Multiple Myeloma Myelodysplasia Stem Cell Transplant Breast |
| Certifications: |
Medical Board Certification: Hematology, American Board of
Internal Medicine, 1990 Medical Oncology, American Board of Internal Medicine, 1989 Internal Medicine, American Board of Internal Medicine, 1987 |
Dr.
Schiller is a well-published clinical investigator in acute and chronic
leukemias, multiple myeloma, and other hematologic malignancies, as well
as in stem cell and bone marrow transplantation. He lectures extensively,
and
has also written for the popular press. He is Chairman of the Los Angeles
Museum of the Holocaust. His research projects include clinical studies
of new drugs, therapies, and bone marrow/stem cell transplantation for
patients with malignancies of the blood or bone marrow such as leukemia,
multiple myeloma,
and lymphoma. He has carried out studies of stem cell transplantation following
high-dose chemotherapy and radiation for acute myelogenous leukemia, one
of the most common types of leukemia in adults. He has also carried out
work
with purified stem cell transplantation for multiple myeloma. He has ongoing
studies using new drugs and therapeutics for acute and chronic lymphocytic
leukemia, acute and chronic myelogenous leukemia, and multiple myeloma;
he
also has studies going on in certain kinds of non-Hodgkin's lymphoma. His
approach is to put into clinical trials new treatments developed in the
laboratory for patients with blood stem cell diseases or cancers of the
bone marrow and
blood.
Articles/Publications
Emmanouilides, C. Colovos, C. Pinter-Brown, L. Hernandez, L. Schiller, G. Territo, M. Rosen, P. Pilot study of fixed-infusion rate gemcitabine with Cisplatin and dexamethasone in patients with relapsed or refractory lymphoma. Clin Lymphoma. 2004; 5(1): 45-9.
Lin, MZ Teitell, MA Schiller, GJ The evolution of antibodies into versatile tumor-targeting agents.. Clinical cancer research : an official journal of the American Association for Cancer Research. . 2005; 11(1): 129-38.
Collisson, EA Lashkari, A Malone, R Paquette, R Emmanouilides, C Territo, MC Schiller, GJ Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of adult acute myelogenous leukemia in first complete remission.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. . 2003; 17(11): 2183-8.
Schiller, GJ Myelodysplasia--therapeutic response to novel therapy and the need for new diagnostic groups.. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K. . 2003; 17(6): 1183-5.
Levine, JE Harris, RE Loberiza, FR Armitage, JO Vose, JM Van Besien, K Lazarus, HM Horowitz, MM Bashey, A Bolwell, BJ Burns, LJ Cairo, MS Champlin, RE Freytes, CO Gibson, J Goldstein, SC Laughlin, MJ Lister, J Marks, DI Maziarz, RT Miller, AM Milone, GA Pavlovsky, S Pecora, AL Rizzo, JD Schiller, G Schouten, HC Zhang, MJ , A comparison of allogeneic and autologous bone marrow transplantation for lymphoblastic lymphoma.. Blood. . 2003; 101(7): 2476-82.
Nemeth, E Valore, EV Territo, M Schiller, G Lichtenstein, A Ganz, T Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.. Blood. . 2003; 101(7): 2461-3.